Given that MCL patients with abundant tumor-infiltrating CD8+ T-cells and low levels of FTX or PCA3 lncRNA can predict poorer overall survival (Figure 11), it may be possible to include WTS analysis during diagnosis to improve MCL prognostication. This evidence concerns the gene CD8A and neoplasm.